GlassScriptPhysician profile
Scott Parratto
NPI 1831177278
$4,159.45
in general payments reported to CMS, 2019-2025
28 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $128 · 2021: $326 · 2022: $470 · 2023: $874 · 2024: $653 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,623 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,623.21 |
| Travel and Lodging | $255.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $912.53 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $758.00 | 2023-2025 | Nuzyra |
| Next Science LLC | $383.59 | 2023-2024 | Blastx, Xperience, Surgx |
| Smith+Nephew, INC. | $307.12 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Stryker Corporation | $255.25 | 2021-2024 | Prostep |
| Melinta Therapeutics, LLC | $233.53 | 2019-2021 | |
| Organogenesis INC. | $201.35 | 2019-2021 | |
| Biocomposites INC | $168.60 | 2019-2024 | Stimulan |
| Kerecis Limited | $160.86 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Embody, INC. | $98.08 | 2022 | |
| Bioventus LLC | $92.68 | 2019-2022 | |
| Urgo Medical North America, LLC | $88.22 | 2023-2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Hartmann USA, INC. | $69.81 | 2020-2025 | Zetuvit Plus, Sorbalgon 4x8 5/Bx |
| Southern Edge Orthopaedics, INC. | $59.90 | 2025 | |
| Nevro Corp. | $52.68 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $42.89 | 2024 | Cmf |
| Solventum Corporation | $35.66 | 2024 | Activ.A.C. |
| Kci USA, INC. | $28.84 | 2022-2023 | Activ.A.C. Ion Progress, Promogran Prisma, Kerramax Care |
| Medtronic, INC. | $28.17 | 2025 | Intellis Adaptivestim |
| Biotissue Holdings INC. | $26.86 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $25.89 | 2023 | Seglentis |
| Averitas Pharma INC. | $23.87 | 2025 | Qutenza |
| Curonix LLC | $22.18 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ebi, LLC | $21.85 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $21.85 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Mimedx Group, INC. | $18.27 | 2025 | |
| Advanced Oxygen Therapy INC. | $13.99 | 2024 | Topical Oxygen Chamber For Extremities |
| Ermi LLC | $6.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Parratto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.